红日药业股价下跌4.25% 上半年净利润同比下滑46.95%

Group 1 - The stock price of Hongri Pharmaceutical is reported at 4.06 yuan, down 0.18 yuan or 4.25% from the previous trading day, with a trading volume of 1.007 million hands and a transaction amount of 419 million yuan [1] - For the first half of 2025, the company achieved an operating income of 2.795 billion yuan, a year-on-year decrease of 6.72%, and a net profit attributable to shareholders of 78.63 million yuan, down 46.95% year-on-year [1] - The net cash flow from operating activities was 384 million yuan, an increase of 8.12% year-on-year [1] Group 2 - The company announced that there are currently no overdue external guarantees and stated its commitment to continuously optimize governance and internal control to enhance operational efficiency and competitiveness [1] - As of the end of the first half of 2025, Chengdu Xingcheng Investment Group Co., Ltd. holds the highest shareholding ratio among the top ten circulating shareholders at 22.24% [1]